FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079797905> ?p ?o ?g. }

• W2079797905 endingPage "6165" @default.
• W2079797905 startingPage "6163" @default.
• W2079797905 abstract "Three mutants (deletion of E196, G291S, and R483P) of steroid 21-hydroxylase (P450c21) from patients with inherited congenital adrenal hyperplasia had reduced activity toward progesterone and 17-hydroxyprogesterone after transient expression in cultured mammalian cells. In addition, both the E196 deletion and the R483P mutant had shorter half-lives than the wild-type enzyme, whereas the half-life of the G291S mutant was comparable with that of the normal protein. These results directly link the clinical situation with the three mutations and suggest that G291 is important for the catalytic activity of P450c21. Three mutants (deletion of E196, G291S, and R483P) of steroid 21-hydroxylase (P450c21) from patients with inherited congenital adrenal hyperplasia had reduced activity toward progesterone and 17-hydroxyprogesterone after transient expression in cultured mammalian cells. In addition, both the E196 deletion and the R483P mutant had shorter half-lives than the wild-type enzyme, whereas the half-life of the G291S mutant was comparable with that of the normal protein. These results directly link the clinical situation with the three mutations and suggest that G291 is important for the catalytic activity of P450c21. Cytochrome P450s are a superfamily of enzymes essential for the oxidative metabolism of different endogenous compounds and xenobiotics (1Nelson D.R. Kamataki T. Waxman D.J. Guengerich F.P. Estabrook R.W. Feyereisen R. Gonzalez F.J. Coon M.J. Gunsalus I.C. Gotoh O. Okuda K. Nebert D.W. DNA Cell Biol. 1993; 12: 1-51Crossref PubMed Scopus (1655) Google Scholar). For many members of the family, enzyme activity varies between individuals due to polymorphisms in the coding parts of the genes. Four cytochrome P450 enzymes are involved in the synthesis of cortisol in the adrenal cortex (2Miller W.L. Endocr. Rev. 1988; 9: 295-318Crossref PubMed Scopus (1187) Google Scholar). Impaired production of cortisol due to reduced function of any of these enzymes causes increased secretion of adrenocorticotropic hormone (ACTH) from the pituitary and congenital adrenal hyperplasia (CAH) 1The abbreviations used are: CAH, congenital adrenal hyperplasia; CYP21, the steroid 21-hydroxylase gene;CYP21P, the steroid 21-hydroxylase pseudogene; P450c21, steroid 21-hydroxylase; 17-OHP, 17-hydroxyprogesterone; PAGE, polyacrylamide gel electrophoresis. (3Miller W.L. Levine L.S. J. Pediatr. 1987; 111: 1-17Abstract Full Text PDF PubMed Scopus (151) Google Scholar). Of particular interest is the cytochrome P450 steroid 21-hydroxylase (P450c21) since more than 90% of all cases of CAH are due to mutations in the gene encoding the enzyme. P450c21 participates in the synthesis of both glucocorticoids and mineralocorticoids. In addition to lack of cortisol and aldosterone, P450c21 deficiency leads to overproduction of adrenal androgens. The disorder has a wide spectrum of manifestations (4White P.C. New M.I. Dupont B. N. Engl. J. Med. 1987; 316: 1519-1524Crossref PubMed Scopus (174) Google Scholar), ranging from a life-threatening neonatal condition in both sexes with ambiguous genitalia in girls, to inconspicuous symptoms of hyperandrogenism in adult women. P450c21 is a protein of 494 amino acids (5White P.C. New M.I. Dupont B. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 5111-5115Crossref PubMed Scopus (492) Google Scholar, 6Higashi Y. Yoshioka H. Yamane M. Gotoh O. Fujii-Kuriyama Y. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 2841-2845Crossref PubMed Scopus (492) Google Scholar). The gene locus has a complicated structure, with an active gene (CYP21) and a highly homologous inactive pseudogene (CYP21P) (5White P.C. New M.I. Dupont B. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 5111-5115Crossref PubMed Scopus (492) Google Scholar, 6Higashi Y. Yoshioka H. Yamane M. Gotoh O. Fujii-Kuriyama Y. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 2841-2845Crossref PubMed Scopus (492) Google Scholar, 7Carroll M.C. Campbell R.D. Porter R.R. Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 521-525Crossref PubMed Scopus (295) Google Scholar, 8White P.C. Grossberger D. Onufer B.J. Chaplin D.D. New M.I. Dupont B. Strominger J.L. Proc. Natl. Acad. Sci. U. S. A. 1985; 82: 1089-1093Crossref PubMed Scopus (407) Google Scholar). Misalignment followed by recombination events between the two homologous genes during meiosis with transfer of sequences from CYP21P to CYP21 account for around 95% of the mutations of P450c21 that lead to CAH (9Wedell A. Thilén A. Ritzén E.M. Stengler B. Luthman H. J. Clin. Endocrinol. Metab. 1994; 78: 1145-1152Crossref PubMed Scopus (275) Google Scholar). Rarely, mutations also arise independently of the pseudogene. We have charcterized three such rare missense mutations, which were found in patients with CAH. To investigate the molecular mechanisms behind the impaired enzyme function displayed by the patients, the mutations were reconstructed by in vitro site-directed mutagenesis, and normal and mutant enzyme was transiently expressed in COS-1 cells. Enzyme activities toward the two natural substrates, 17-hydroxyprogesterone (17-OHP) and progesterone, were determined. In addition, to assess whether the impaired function resulted from reduced stability of the mutant proteins, their half-lives were determined by pulse-chase experiments followed by immunoprecipitation. The CYP21 mutations were found in five patients with CAH. The siblings numbers B39 and B40, as well as patient number B103, have been reported previously (10Wedell A. Ritzén M.E. Haglund-Stengler B. Luthman H. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 7232-7236Crossref PubMed Scopus (134) Google Scholar, 11Wedell A. Luthman H. Hum. Genet. 1993; 91: 236-240Crossref PubMed Scopus (78) Google Scholar), whereas the younger brother of B103, patient E. I., as well as patient number 1293 have not been described. Genotyping was performed by allele-specific polymerase chain reaction (12Wedell A. Luthman H. Hum. Mol. Genet. 1993; 2: 499-504Crossref PubMed Scopus (141) Google Scholar) and direct sequencing of CYP21 (10Wedell A. Ritzén M.E. Haglund-Stengler B. Luthman H. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 7232-7236Crossref PubMed Scopus (134) Google Scholar). Numbering of nucleotides and amino acids follows the reference sequence of White et al. (5White P.C. New M.I. Dupont B. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 5111-5115Crossref PubMed Scopus (492) Google Scholar). Subjects numbers B39 and B40 were compound heterozygotes, with the unique R483P mutation on one allele and the well-known I172N mutation (13Amor M. Parker K.L. Globerman H. New M.I. White P.C. Proc. Natl. Acad. Sci. U. S. A. 1988; 85: 1600-1604Crossref PubMed Scopus (209) Google Scholar) on the other. They had a moderate form of the disease, with early clitoral enlargement in the female sibling but without salt-wasting. Subject number B103 and his younger brother E. I. had inherited the unique G291S mutation on their paternal allele, whereas the maternal allele was deleted. They had the most severe, salt-wasting form of CAH. Patient number 1293 was a compound heterozygote for the I172N mutation and a novel sequence aberration, where nucleotides 1158–1160 (AGG) in exon 5 of CYP21 were deleted, causing loss of a glutamic acid residue at position 196 in P450c21, delE196 (Fig. 1). This female patient was born in Norway in 1968 and was affected with a moderate form of CAH with some signs of prenatal virilization but without salt-wasting. pGEM constructs as well as pCMV4 expression vectors were constructed to contain the cDNAs encoding the wild-type and the three mutant enzymes, essentially as described previously (14Nikoshkov A. Lajic S. Holst M. Wedell A. Luthman H. J. Clin. Endocrinol. Metab. 1997; 82: 194-199Crossref PubMed Scopus (61) Google Scholar). The plasmids thus generated were named pGEM-CYP21 (encoding the wild-type enzyme), pGEM-CYP21(delE196), pGEM-CYP21(G291S), pGEM-CYP21(R483P), and pCMV4-CYP21, pCMV4-CYP21(delE196), pCMV4-CYP21(G291S), and pCMV4-CYP21(R483P). All constructs were sequenced to verify the correct incorporation of the mutations and to exclude additional aberrations. Enzymatic activities of the mutants and the wild-type enzyme were determined in intact COS-1 cells after transient expression, using 17-OHP and progesterone as substrates (14Nikoshkov A. Lajic S. Holst M. Wedell A. Luthman H. J. Clin. Endocrinol. Metab. 1997; 82: 194-199Crossref PubMed Scopus (61) Google Scholar). Estimation of translation efficiency was performed using the TNT Coupled Reticulocyte Lysate System (Promega, Madison, WI) according to the instructions of the manufacturer. An ATG sequence was present in the multiple cloning site of pGEM-CYP21, upstream of CYP21, but in a different reading frame. This initiation codon was destroyed by SphI cleavage, T4 polymerase treatment, and blunt-end ligation, which resulted in the removal of four nucleotides in this region. Two μg of plasmids pGEM-CYP21, pGEM-CYP21(delE196), pGEM-CYP21(G291S), and pGEM-CYP21(R483P) were used for transcription/translation, incubation times were 5, 10, 15, and 20 min, and [35S]methionine incorporation was measured by scintillation counting after trichloroacetic acid precipitation of translation products. The translation products obtained after a 60-min incubation were subjected to SDS-PAGE to verify the integrity of the 55-kDa 21-hydroxylase protein. COS-1 cells were transfected (14Nikoshkov A. Lajic S. Holst M. Wedell A. Luthman H. J. Clin. Endocrinol. Metab. 1997; 82: 194-199Crossref PubMed Scopus (61) Google Scholar) with the expression constructs pCMV4-CYP21, pCMV4-CYP21(delE196), pCMV4-CYP21(G291S), or pCMV4-CYP21(R483P) and incubated for 30 h. Cells were then labeled (100 μCi of [35S]methionine) and immunoprecipitated as described (15Dorner A.J. Kaufman R.J. Methods Enzymol. 1990; 185: 577-596Crossref PubMed Scopus (57) Google Scholar), and the immunoprecipitates were analyzed on 10% SDS-PAGE gels. The rabbit P450c21 antiserum used was kindly provided by Dr. Peter F. H. Hall, Prince of Wales Hospital, Randwick, Australia. Labeled proteins were visualized by autoradiography, and their intensities were quantified using a phosphoimager (Fujix Bas 1000 Bio-Imaging Analyzer, Fuji, Japan). For each time point examined (within each mutant), immunoprecipitated material corresponded to equal total cell protein as determined by Bradford (16Bradford M.M. Anal. Biochem. 1976; 72: 248-254Crossref PubMed Scopus (216428) Google Scholar). The degradation profiles and half-lives of the different P450c21s were calculated using a curve-fitting program (FigP, Elsevier Biosoft Ver. 5.0). TableI shows that all mutants had a fraction of the activity of the wild-type enzyme. The delE196 mutant retained 6% activity toward 17-OHP and 23% activity toward progesterone. The G291S mutant displayed 0.8% of normal activity in both cases, whereas the R483P mutant displayed 1% of normal activity toward 17-OHP and 2.2% activity toward progesterone. The activity of the wild-type enzyme was defined as 100%.Table IPercentage of wild-type activity for P450c21 mutants (delE196, G291S, and R483P) in intact COS-1 cells17-OHPProgesteronedelE1966.0 ± 1.523 ± 2.3G291S0.8 ± 0.40.8 ± 0.4R483P1.0 ± 0.072.2 ± 0.91-a Activities are expressed as percentage of wild-type activity that is arbitrarily defined as 100%. Percent conversion was determined for 17-hydroxyprogesterone (17-OHP) to 11-deoxycortisol, and progesterone to 11-deoxycorticosterone, using substrate concentrations of 0.5 μmol/liter in both cases (non-saturated conditions). Actual specific activity of the wild-type enzyme was 40.5 ± 4.4 pmol × mg−1 × min−1 for 17-OHP and 31.1 ± 3.8 pmol × mg−1 × min−1 for progesterone. All values represent the means from three separate transfections ± S.E. Open table in a new tab 1-a Activities are expressed as percentage of wild-type activity that is arbitrarily defined as 100%. Percent conversion was determined for 17-hydroxyprogesterone (17-OHP) to 11-deoxycortisol, and progesterone to 11-deoxycorticosterone, using substrate concentrations of 0.5 μmol/liter in both cases (non-saturated conditions). Actual specific activity of the wild-type enzyme was 40.5 ± 4.4 pmol × mg−1 × min−1 for 17-OHP and 31.1 ± 3.8 pmol × mg−1 × min−1 for progesterone. All values represent the means from three separate transfections ± S.E. To investigate whether the three sequence alterations of CYP21 had any effect on the translation of the gene, an in vitro-coupled transcription/translation assay was employed. None of the mutations affected the rate of translation in this in vitro system (data not shown). Fig. 2 shows the degradation profiles of immunoprecipitated wild-type and mutant P450c21s for chase periods of up to 4 h. Fig. 3 shows the same results after quantification of the immunoreactive bands with a phosphoimager. The degradation of each enzyme species is expressed as percentage of remaining counts at each time point, with the level at point 0 defined as 100%. The level of expression at 0 h in terms of actual counts was comparable between the normal and mutant enzymes (data not shown). Fig. 3 indicates that the wild-type enzyme was the most stable, whereas all mutants had decreased stability. The R483P was most rapidly degraded and was barely detectable at the end of the 4-h chase. Half-lives were calculated as 1 h, 10 min (wild-type P450c21), 30 min (delE196), 55 min (G291S), and 20 min (R483P).Figure 3Quantification of degradation profiles of wild-type and mutant P450c21s transiently expressed in COS-1 cells. Results are expressed as percentage of remaining protein, with the amount at time 0 (just before chase) defined as 100%. •, wild-type P450c21; ▵, delE196 mutant; ▪, G291S mutant; □, R483P mutant. Values for 0, 1, 2, 3, and 4 h represent the average of two independent pulse-chase experiments.View Large Image Figure ViewerDownload (PPT) Defective function of P450c21 is the major cause of CAH. To examine whether this was the case for three novel mutant P450c21s from patients with CAH, we studied the enzymatic activities and half-lives of the mutants. All three mutations impaired enzyme activity toward the two natural substrates of the enzyme when assayed after transient transfection in cultured cells. The delE196 mutant was partially active toward both substrates. P450c21 G291S resulted in a protein with less than 1% of normal activity, whereas the R483P mutant retained 1–2% of the activity of the native enzyme. This is in agreement with the clinical phenotypes of the patients. Those carrying delE196 and R483P had moderate forms of CAH and were compound heterozygotes with the I172N mutation on the other chromosome. The latter mutation is generally associated with the moderate, simple virilizing phenotype (9Wedell A. Thilén A. Ritzén E.M. Stengler B. Luthman H. J. Clin. Endocrinol. Metab. 1994; 78: 1145-1152Crossref PubMed Scopus (275) Google Scholar,17Speiser P.W. Dupont J. Zhu D. Serrat J. Buegeleisen M. Tusie-Luna M.-T. Lesser M. New M.I. White P.C. J. Clin. Invest. 1992; 90: 584-595Crossref PubMed Scopus (505) Google Scholar, 18Wilson R.C. Mercado A.B. Cheng K.C. New M.I. J. Clin. Endocrinol. Metab. 1995; 80: 2322-2329Crossref PubMed Google Scholar). The brothers carrying G291S had deleted their 21-hydroxylase gene of the other chromosome and had the most severe, salt-wasting form of the disease. To examine whether the reduced enzymatic activity of the mutants was a consequence of reduced stability rather than decreased turnover of substrate, the half-lives of the wild-type and the three mutant enzymes were compared by pulse-chase experiments. The half-life of the wild-type P450c21 (1 h, 10 min) was longer than those of all mutants. The delE196 and R483P mutants were most rapidly degraded (half-lives 30 and 20 min, respectively). These data suggest that the phenotypes resulting from the delE196 and R483P mutants can be explained in view of little if any available P450c21. In contrast, since the half-life of G291S (55 min) and wild-type P450c21 (1 h, 10 min) were comparable, it seems that G291 plays an essential role in the maintenance of enzyme activity. Generally little is known about structure-function relationships of mammalian cytochrome P450 enzymes. One reason is that mammalian P450s contain hydrophobic segments and are therefore difficult to crystallize. However, three-dimensional structures of four nonmembrane-associated bacterial cytochrome P450s (P450cam (19Poulos T.L. Finzel B.C. Howard A.J. J. Mol. Biol. 1987; 195: 687-700Crossref PubMed Scopus (1295) Google Scholar), P450BM-3 (20Ravichandran K.G. Boddupalli S.S. Hasemann C.A. Peterson J.A. Deisenhofer J. Science. 1993; 261: 731-736Crossref PubMed Scopus (910) Google Scholar), P450terp (21Hasemann C.A. Ravichandran K.G. Peterson J.A. Deisenhofer J. J. Mol. Biol. 1994; 236: 1169-1185Crossref PubMed Scopus (380) Google Scholar), and P450eryF (22Cupp-Vickery J.R. Poulos T.L. Nat. Struct. Biol. 1995; 2: 144-153Crossref PubMed Scopus (406) Google Scholar)) have been determined. A correlation of important residues among different classes of cytochrome P450s has been made by Nelson and Strobel (23Nelson D.R. Strobel H.W. J. Biol. Chem. 1988; 263: 6038-6050Abstract Full Text PDF PubMed Google Scholar) after alignment of 34 different P450s, including P450c21 and P450cam (24Iida T. Nakahori Y. Komaki R. Mori E. Hayashi N. Tsutsumi O. Taketani Y. Nakagome Y. Hum. Mol. Genet. 1994; 3: 1437-1438Crossref PubMed Scopus (23) Google Scholar). According to their model, G291 would be hydrogen-bonded with T295 to form together an oxygen-binding pocket. Another model obtained from the structural information of P450BM-3 (20Ravichandran K.G. Boddupalli S.S. Hasemann C.A. Peterson J.A. Deisenhofer J. Science. 1993; 261: 731-736Crossref PubMed Scopus (910) Google Scholar) implies that residues 291–297 of human P450c21 are involved in proton transfer from water to heme. Thus, G291 is intricately involved in catalysis according to two different models, and our experimental data suggest that this particular residue is essential to maintain enzyme activity. In conclusion, enzymatic activity and stability analyses of three naturally occurring mutants of P450c21 from patients with CAH provided a potential explanation for the clinical symptoms and identified residues important for the in vitro stability and catalytic activity of the enzyme." @default.
• W2079797905 created "2016-06-24" @default.
• W2079797905 creator A5010261264 @default.
• W2079797905 creator A5010714367 @default.
• W2079797905 creator A5034735829 @default.
• W2079797905 creator A5053844285 @default.
• W2079797905 creator A5066408139 @default.
• W2079797905 creator A5071077300 @default.
• W2079797905 creator A5082800617 @default.
• W2079797905 date "1998-03-01" @default.
• W2079797905 modified "2023-10-16" @default.
• W2079797905 title "Naturally Occurring Mutants of Human Steroid 21-Hydroxylase (P450c21) Pinpoint Residues Important for Enzyme Activity and Stability" @default.
• W2079797905 cites W1963680434 @default.
• W2079797905 cites W1964331183 @default.
• W2079797905 cites W2000051743 @default.
• W2079797905 cites W2003754342 @default.
• W2079797905 cites W2010897322 @default.
• W2079797905 cites W2015197852 @default.
• W2079797905 cites W2016469762 @default.
• W2079797905 cites W2033342330 @default.
• W2079797905 cites W2059708085 @default.
• W2079797905 cites W2062953189 @default.
• W2079797905 cites W2085602910 @default.
• W2079797905 cites W2086823401 @default.
• W2079797905 cites W2087018701 @default.
• W2079797905 cites W2092019850 @default.
• W2079797905 cites W2112200733 @default.
• W2079797905 cites W2144739237 @default.
• W2079797905 cites W2147452643 @default.
• W2079797905 cites W2150946709 @default.
• W2079797905 cites W2215417236 @default.
• W2079797905 cites W2413525758 @default.
• W2079797905 cites W4293247451 @default.
• W2079797905 doi "https://doi.org/10.1074/jbc.273.11.6163" @default.
• W2079797905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9497336" @default.
• W2079797905 hasPublicationYear "1998" @default.
• W2079797905 type Work @default.
• W2079797905 sameAs 2079797905 @default.
• W2079797905 citedByCount "46" @default.
• W2079797905 countsByYear W20797979052012 @default.
• W2079797905 countsByYear W20797979052013 @default.
• W2079797905 countsByYear W20797979052014 @default.
• W2079797905 countsByYear W20797979052016 @default.
• W2079797905 countsByYear W20797979052017 @default.
• W2079797905 countsByYear W20797979052018 @default.
• W2079797905 countsByYear W20797979052019 @default.
• W2079797905 countsByYear W20797979052020 @default.
• W2079797905 countsByYear W20797979052021 @default.
• W2079797905 countsByYear W20797979052022 @default.
• W2079797905 countsByYear W20797979052023 @default.
• W2079797905 crossrefType "journal-article" @default.
• W2079797905 hasAuthorship W2079797905A5010261264 @default.
• W2079797905 hasAuthorship W2079797905A5010714367 @default.
• W2079797905 hasAuthorship W2079797905A5034735829 @default.
• W2079797905 hasAuthorship W2079797905A5053844285 @default.
• W2079797905 hasAuthorship W2079797905A5066408139 @default.
• W2079797905 hasAuthorship W2079797905A5071077300 @default.
• W2079797905 hasAuthorship W2079797905A5082800617 @default.
• W2079797905 hasBestOaLocation W20797979051 @default.
• W2079797905 hasConcept C104317684 @default.
• W2079797905 hasConcept C143065580 @default.
• W2079797905 hasConcept C181199279 @default.
• W2079797905 hasConcept C185592680 @default.
• W2079797905 hasConcept C2780321258 @default.
• W2079797905 hasConcept C2780902042 @default.
• W2079797905 hasConcept C55493867 @default.
• W2079797905 hasConcept C71315377 @default.
• W2079797905 hasConcept C86803240 @default.
• W2079797905 hasConceptScore W2079797905C104317684 @default.
• W2079797905 hasConceptScore W2079797905C143065580 @default.
• W2079797905 hasConceptScore W2079797905C181199279 @default.
• W2079797905 hasConceptScore W2079797905C185592680 @default.
• W2079797905 hasConceptScore W2079797905C2780321258 @default.
• W2079797905 hasConceptScore W2079797905C2780902042 @default.
• W2079797905 hasConceptScore W2079797905C55493867 @default.
• W2079797905 hasConceptScore W2079797905C71315377 @default.
• W2079797905 hasConceptScore W2079797905C86803240 @default.
• W2079797905 hasIssue "11" @default.
• W2079797905 hasLocation W20797979051 @default.
• W2079797905 hasOpenAccess W2079797905 @default.
• W2079797905 hasPrimaryLocation W20797979051 @default.
• W2079797905 hasRelatedWork W1969421403 @default.
• W2079797905 hasRelatedWork W2071476973 @default.
• W2079797905 hasRelatedWork W2150065613 @default.
• W2079797905 hasRelatedWork W2150914257 @default.
• W2079797905 hasRelatedWork W2156423843 @default.
• W2079797905 hasRelatedWork W2156674132 @default.
• W2079797905 hasRelatedWork W4246662077 @default.
• W2079797905 hasRelatedWork W4247436401 @default.
• W2079797905 hasRelatedWork W4252497173 @default.
• W2079797905 hasRelatedWork W214510971 @default.
• W2079797905 hasVolume "273" @default.
• W2079797905 isParatext "false" @default.
• W2079797905 isRetracted "false" @default.
• W2079797905 magId "2079797905" @default.
• W2079797905 workType "article" @default.